Quantcast
Last updated on April 19, 2014 at 12:41 EDT

Latest Unsolved problems in neuroscience Stories

2012-08-21 23:35:14

People with Parkinson's disease performed markedly better on a test of working memory after a night's sleep, and sleep disorders can interfere with that benefit, researchers have shown. While the classic symptoms of Parkinson's disease include tremors and slow movements, Parkinson's can also affect someone's memory, including "working memory." Working memory is defined as the ability to temporarily store and manipulate information, rather than simply repeat it. The use of working memory is...

Double Whammy From Brain Enzyme For Alzheimer's Disease
2012-08-20 08:22:40

Sanford-Burnham researchers discover that an enzyme known for generating toxic brain plaques in Alzheimer's disease also causes additional memory and cognitive deficits via a separate mechanism The underlying causes of Alzheimer's disease are not fully understood, but a good deal of evidence points to the accumulation of β-amyloid, a protein that's toxic to nerve cells. β-amyloid is formed by the activity of several enzymes, including one called BACE1. Most Alzheimer's disease...

2012-08-14 02:28:54

Trial Will Test Efficacy of NeuRx Diaphragm Pacing System in People with Lou Gehrig's Disease TUCSON, Ariz., and WASHINGTON, Aug. 14, 2012 /PRNewswire-USNewswire/ -- The Muscular Dystrophy Association (MDA) and The ALS Association today announced a joint commitment to provide funding for a phase 2 clinical trial that will test efficacy of the NeuRx Diaphragm Pacing System (DPS) in people with amyotrophic lateral sclerosis (ALS). (Logo:...

2012-08-12 23:03:34

The ALS Association, Upstate New York Chapter, announces its annual Walk to Defeat ALS® on Sunday, August 12, 2012 at Otsiningo Park, Binghamton, N.Y. The Walk is open to the public, and all funds raised will be donated to The ALS Association, Upstate New York Chapter. Syracuse, New York (PRWEB) August 11, 2012 The ALS Association, Upstate New York Chapter, announces its annual Walk to Defeat ALS® on Sunday, August 12, 2012 at Otsiningo Park, Binghamton, N.Y. The Walk is open to the...

2012-08-08 06:24:13

WASHINGTON, Aug. 8, 2012 /PRNewswire-USNewswire/ -- The ALS Association announced today its latest research awards that include funding commitments of $4 million to researchers in 31 laboratories in the United States, United Kingdom, Belgium, Germany and Canada. These awards are part of its Translational Research Advancing Therapies for ALS (TREAT ALS(TM)) program, through which The Association funds a diverse portfolio of research to find treatments and a cure for Lou Gehrig's Disease. ALS...

2012-08-07 07:36:19

Researchers from Brigham and Women's Hospital (BWH) are the first to discover that changes in monocytes (a type of white blood cell) are a biomarker for amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease. This finding also brings the medical community a step closer toward a new treatment for the debilitating neurological disease that affects approximately 30,000 Americans. The study will be published online in The Journal of Clinical Investigation on August 6, 2012. In...

2012-08-06 06:24:27

WASHINGTON, Aug. 6, 2012 /PRNewswire-USNewswire/ -- In a new study on amyotrophic lateral sclerosis (ALS) published today in the Journal of Clinical Investigation, which was funded in part by The ALS Association, and conducted by researchers at Harvard Medical School, Tufts Medical School, Brigham and Women's Hospital and Massachusetts General Hospital, scientists have identified a biomarker in the blood that signals the earliest stages of the disease. While further studies to validate this...

2012-07-31 10:33:19

An international team of scientists led by researchers at Mount Sinai School Medicine have discovered that a drug that had previously yielded conflicting results in clinical trials for Alzheimer's disease effectively stopped the progression of memory deterioration and brain pathology in mouse models of early stage Alzheimer's disease. The findings, published July 31, 2012 in Molecular Psychiatry, demonstrate renewed potential for this compound and could lead to clinical trials in patients...

2012-07-25 13:56:17

In a study published June 25 in the Journal of Neuroscience, a collaborative team of researchers led by Linda J. Van Eldik, director of the University of Kentucky Sanders-Brown Center on Aging, and D. Martin Watterson of the Northwestern University Feinberg School of Medicine, present results showing that a new central nervous system drug compound can reduce Alzheimer's pathology in a mouse model of the disease. The drug, called MW-151, is a selective suppressor of brain inflammation and...

Yoga Reduces Stress For Caregivers Of Those With Dementia
2012-07-25 10:19:02

Connie K. Ho for redOrbit.com — Your Universe Online Inhale. Exhale. Stretch. Repeat. These are just a few steps of yoga, a therapeutic workout that has gained in popularity over the years. Researchers recently found that a particular type of yoga that allows participants to practice brief meditation on a daily basis will help decrease stress for people who take care of patients with Alzheimer´s and dementia. According to scientists from the University of California, Los...